What Is Prior Authorization?

What Is Prior Authorization?

Prior authorization (PA) -- sometimes called pre-authorization or pre-approval -- is a process in which a health insurance plan requires approval before it will cover a specific medication, procedure, or service. The insurance company reviews the request to determine whether the treatment meets its criteria for medical necessity before agreeing to pay for it.

In practice, this means that even if a physician prescribes a medication, the pharmacy may not be able to fill it until the insurance company has reviewed and approved the request. Prior authorization is common across many drug classes, but it is especially prevalent with GLP-1 receptor agonists due to their high cost and growing demand.

Why GLP-1 Medications Commonly Require PA

GLP-1 receptor agonists such as Ozempic, Wegovy, Mounjaro, and Zepbound carry list prices that can exceed $1,000 per month. Insurance plans use prior authorization as a cost-management tool to ensure these medications are being prescribed for appropriate clinical indications. PA requirements vary by insurer, but most plans require some form of pre-approval for GLP-1 RAs, particularly when prescribed for weight management.

Typical Prior Authorization Requirements

While specific criteria differ between insurance plans, prior authorization for GLP-1 medications commonly requires documentation of:

• Body mass index (BMI): For weight management indications, most plans require a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia.
• Failed diet and exercise documentation: Many insurers require evidence that the patient has attempted structured lifestyle modifications (diet and exercise programs) for a specified period, often 3 to 6 months, before approving medication.
• Comorbidity documentation: Plans may require documentation of specific weight-related health conditions.
• Previous medication trials: Some plans require that patients have tried and failed (or been unable to tolerate) other medications first. This is known as step therapy.
• A1C levels: For diabetes indications, plans typically require documentation of recent A1C levels demonstrating inadequate blood sugar control with current treatment.
• Prescriber qualifications: Certain plans may require that the prescription come from a specialist such as an endocrinologist rather than a primary care physician.

How Long Does Prior Authorization Take?

The timeline for prior authorization decisions varies:

• Standard requests: Most insurance plans are required to respond within 5 to 15 business days for non-urgent requests.
• Urgent requests: If a physician determines the standard timeline could seriously harm the patient's health, an expedited review may be completed within 24 to 72 hours.
• Pharmacy-initiated PAs: In many cases, the pharmacy will identify that a PA is needed at the point of sale and notify the prescriber, who must then submit the request. This can add time to the overall process.

Patients should anticipate that the PA process may take one to three weeks from the initial prescription to the final decision.

What to Do If Prior Authorization Is Denied

A denial does not necessarily mean the medication will never be covered. Options after a denial include:

• Appeal the decision: Most insurance plans have a formal appeals process. The prescribing physician can submit additional clinical documentation supporting the medical necessity of the medication.
• Peer-to-peer review: The prescriber may request a direct conversation with the insurance company's medical reviewer to discuss the clinical rationale.
• Try an alternative medication: If the plan requires step therapy, completing a trial of the required medication may satisfy the PA criteria for the originally prescribed drug.
• Contact the manufacturer: Pharmaceutical companies often offer patient assistance programs, savings cards, or copay assistance that may reduce out-of-pocket costs.
• External review: In some states, patients have the right to request an independent external review of the insurer's denial.

Step Therapy Requirements

Step therapy, sometimes called "fail first," is a protocol in which insurance plans require patients to try one or more less expensive medications before approving a more costly option. For GLP-1 medications, this might mean a plan requires a trial of metformin or a sulfonylurea for diabetes, or an older weight-loss medication, before approving a GLP-1 RA.

Step therapy timelines and required medications vary by plan. Patients and providers should review the specific formulary and step therapy protocols of their insurance plan. A healthcare provider can help navigate these requirements and advocate for the most clinically appropriate treatment.